MBRX Message Board Post 10862324 | Moleculin Biotech Inc.
home / stock / mbrx / mbrx message board
(investorshangout)
Posted on: May/07/2019 14:25:40
Source: investorshangout
https://investorshangout.com/post/view?id=5430791
whytestocks: $MBRX News Article - Moleculin Announces Additional Positive Interim Results in First Cohort of Phas
News, Short Squeeze, Breakout and More Instantly...
-
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
-
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
-
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...